Literature DB >> 7597676

Corticosteroid sparing agents in asthma.

J M Hill1, A E Tattersfield.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7597676      PMCID： PMC1021234          DOI： 10.1136/thx.50.5.577

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  55 in total

1.  Chrysotherapy in the treatment of corticosteroid-dependent asthma.

Authors:  W B Klaustermeyer; D T Noritake; F K Kwong
Journal:  J Allergy Clin Immunol       Date:  1987-05       Impact factor: 10.793

2.  Is leukotriene B4 an important mediator in human IgE-mediated allergic reactions?

Authors:  S P Peters; H S Freeland; S J Kelly; U Pipkorn; R M Naclerio; D Proud; R P Schleimer; L M Lichtenstein; J E Fish
Journal:  Am Rev Respir Dis       Date:  1987-06

3.  Modulation of the release of histamine and arachidonic acid metabolites from human basophils and mast cells by auranofin.

Authors:  G Marone; M Columbo; D Galeone; G Guidi; A Kagey-Sobotka; L M Lichtenstein
Journal:  Agents Actions       Date:  1986-04

4.  Evidence that cyclosporine inhibits cell-mediated immunity primarily at the level of the T lymphocyte rather than the accessory cell.

Authors:  A Granelli-Piperno; M Keane; R M Steinman
Journal:  Transplantation       Date:  1988-08       Impact factor: 4.939

5.  Methotrexate in the treatment of corticosteroid-dependent asthma. A double-blind crossover study.

Authors:  M F Mullarkey; B A Blumenstein; W P Andrade; G A Bailey; I Olason; C E Wetzel
Journal:  N Engl J Med       Date:  1988-03-10       Impact factor: 91.245

6.  An open study of auranofin in the treatment of steroid-dependent asthma.

Authors:  D I Bernstein; I L Bernstein; S S Bodenheimer; R G Pietrusko
Journal:  J Allergy Clin Immunol       Date:  1988-01       Impact factor: 10.793

7.  Immunosuppressive effects of cyclosporin A on cloned T cells.

Authors:  K C Herold; D W Lancki; R L Moldwin; F W Fitch
Journal:  J Immunol       Date:  1986-02-15       Impact factor: 5.422

8.  Cryptococcosis associated with low-dose methotrexate for arthritis.

Authors:  M Altz-Smith; L G Kendall; A M Stamm
Journal:  Am J Med       Date:  1987-07       Impact factor: 4.965

9.  Inhibition of basophil histamine release by methotrexate.

Authors:  H Nolte; P Stahl Skov
Journal:  Agents Actions       Date:  1988-04

10.  Studies on the effect of methotrexate on macrophage function.

Authors:  S K Hu; Y L Mitcho; A L Oronsky; S S Kerwar
Journal:  J Rheumatol       Date:  1988-02       Impact factor: 4.666
View more
  2 in total

Review 1.  A risk-benefit assessment of methotrexate in corticosteroid-dependent asthma.

Authors:  T R Shulimzon; R J Shiner
Journal:  Drug Saf       Date:  1996-10       Impact factor: 5.606

2.  Safety and efficacy of extracorporeal granulocyte and monocyte adsorption apheresis in patients with severe persistent bronchial asthma.

Authors:  Tamotsu Ishizuka; Tadayoshi Kawata; Yasuo Shimizu; Mitsuyoshi Utsugi; Katsuaki Endou; Takeshi Hisada; Kunio Dobashi; Tsugio Nakazawa; Masatomo Mori
Journal:  Inflammation       Date:  2005-02       Impact factor: 4.092
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.